Raising the Bar on Leadership for the Evolving CFO/Financial Executive

July 9, 2020 8:00 AM - 9:00 AM

Webinar, click "live-stream" button to view

Add to Calendar 7/9/2020 8:00:00 AM 7/9/2020 9:00:00 AM Raising the Bar on Leadership for the Evolving CFO/Financial Executive

Within the life science eco-system, the role of the CFO/financial executive continues to shift. CFOs and financial executives are assuming increasingly complex roles, from managing day-to-day responsibilities, to driving value creation across the business, to navigating the markets and volatility. As a ‘strategic partner’ to the CEO, CFOs/financial executives must master the art of balance and agility with appropriate skills, talents, experiences and support.


To start, below are five key characteristics that exemplify the evolving life science CFO/financial executive:

  • Holistic perspective encompassing the entire value chain
  • Insight and ability to communicate business drivers
  • Eye for the right kind of talent
  • Facility for cultural change
  • Integrity and interpersonal skills needed to pull all these together


How can you become a finance leader and recruit those who will support and succeed you? What should emerging finance leaders think about as they step into the CFO/financial executive role? Or for the seasoned executive who is taking on their 2nd or 3rd role, what should you keep in mind to ensure your ability to consistently lead with success?

Join us as we draw on the wisdom of our panelists to understand and discuss the art and expertise of today’s ‘successful, cross functional’ life science CFO/financial executive. Sponsored by the MassBio Business Development and Finance forum working group. MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Webinar, click "live-stream" button to view
Head of Strategic Finance and Investor Relations, Jounce Tx & MassBio BD/Finance Forum Co-Chair
Komal Joshi is the head of strategic finance and investor relations at Jounce Therapeutics, a clinical-stage immunotherapy company that is developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to cancer patients. Prior to Komal’s transition to industry, she spent 15+ years in financial services, beginning with her role as a sell-side equity research analyst. Komal then moved to healthcare investment banking where she executed on capital raising and M&A advisory for emerging to large cap healthcare product and services companies. Altogether, she brings almost 20 years of increasing industry and financial services experiences. Komal has a BS in Finance from Boston College and an MBA from Columbia Business School.